Jay Cohn, MD - Fairview Health Services
 
Print
Jay Cohn, MD

Philosophy of Care:

Dr. Cohn has concentrated on developing cardiovascular assessment and therapy procedures, and written extensively about hypertension, congestive heart failure, vascular compliance and other related topics. 

Medical Title:

Academic Appointments:

Services:

Specialties:

Clinical Interests:

Languages Spoken:

Education:

Board Certifications:

New York State College Scholarship (competitive);

New York State Medical School Scholarship (competitive); Annual Award,

New York State Arthritis and Rheumatism Foundation, 1955;

Alpha Omega Alpha, Cornell University Medical College, 1955;

Arthur S. Flemming Award, Federal Government Service, 1969;

Distinguished Service Award, American Heart Association, 1982;

William S. Harvey Award, 1987; Sir Thomas Lauder Brunton Award, 1988;

The 400 Best Doctors in America, Good Housekeeping, 1992, 1996;

The 250 Top Doctors in Twin City Area, Minneapolis-St Paul Magazine, 1992;

Listed in Best Doctors in America, 1992-1999,

Woodward/White, Inc.; Medical Alley Award for Outstanding Contribution in Research and Development, 1993;

Who's Who in Medicine and Healthcare; The Best Doctors in America: Central Region 1996-1997;

Discovery Award, New Jersey Affiliate American Heart Association, 1998;

Scientific Councils' Distinguished Achievement Award, American Heart Association, 1998;

Council on High Blood Pressure Research (AHA) - Novartis Award in Hypertension Research, 2000;

International Scientist of the Year – 2003, International Biographical Centre, Cambridge, U.K.;

Arrigo Recordati International Prize for Scientific Research: Lifetime Achievement in Heart Failure, 2003;

Ignacio Chavez Medal of Honor, Interamerican Society of Heart Failure, Acapulco, 2003;

Lifetime Achievement in Research, Henry Ford Forum on Heart Failure, Detroit, Michigan, 2003;

Academic Health Center Academy for Excellence in Health Research, University of Minnesota, 2003;

James B. Herrick Award, American Heart Association, 2003;

American College of Cardiology, Distinguished Scientist Award (Clinical Domain), 2005;

Heart Failure Society of America Lifetime Achievement Award, 2006;

Clinical Scholar Award, University of Minnesota, 2006; Mastership, American College of Physicians, 2007;

Alumni Association Award of Distinction, Weill Medical College of Cornell University, 2007;

International Academy of Cardiovascular Sciences Life Achievement Award, 2009;

Distinguished Scientist Award, American Heart Association, 2010

Franciosa JA, Guiha NH, Limas CJ, Rodriguera E, Cohn JN: Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1972; 1: 650-654;

Cohn JN, Guiha NH, Broder MI, Limas CJ: Right ventricular infarction: Clinical and hemodynamicfeatures. Am J Cardiol 1974; 33: 209-214;

Guiha NH, Cohn JN, Mikulic E, Franciosa JA, Limas CJ: Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med 1974; 291: 587-592;

Cohn JN, Franciosa JA, Francis GS, Archibald D, Tristani F, Fletcher R, Montero A, Cintron G, Clarke J, Hager D, Saunders R, Cobb F, Smith R, Loeb H, Settle H: Effect of short-term infusion of sodium nitroprusside on mortality rate in acute myocardial infarction complicated by left ventricular failure. New Engl J Med 1982; 306: 1129-1135;

Cohn JN. Levine TB Olivari MT, Garberg V, Lura D, Francis GS, Simon A: Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. New Eng J Med 1984; 311: 819-823;

Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT). N Engl J Med 1986;314:1547-52;

Cohn JN, Goldstein S, Greenberg BH, Lorell BH, Bourge RC, Jaski BE, Gottlieb SO, McGrew, III, F, DeMets DL, White BG, for the Vesnarinone Trial Investigators: A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. NEJM 1998;339:1810-1816;

Cohn JN, Tognoni G, for the Valsartan Heart Failure Trial Investigators. A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345:1667-75;

Cohn JN, Hoke L, Whitwam W, Sommers PA, Taylor AL, Duprez D, Roessler R, Florea N. Screening for early detection of cardiovascular disease in asymptomatic individuals. Am Heart J 2003;146:679-685;

Taylor AL, Ziesche S, Yancy C, Carson P, D’Agostino R, Jr, Ferdinand K, Taylor M, Adams K, Sabolinski M, Worcel M, Cohn JN, for the African-American Heart Failure Trial Investigators. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med 2004;351(20):2049-57

 
 Visit Other Fairview Sites 
 
 
(c) 2012 Fairview Health Services. All rights reserved.